期刊文献+

人ICOS胞外区腺病毒载体的构建与鉴定 被引量:2

Construction and identification of human ICOS extracellular domain gene recombinant adenovirus
下载PDF
导出
摘要 目的利用细菌内同源重组法构建含ICOS胞外区基因的重组腺病毒。方法用基因工程的方法将ICOS胞外区的cDNA片段插入穿梭质粒pAdTrack-CMV中,形成转移质粒pAdtrack-cmv-ICOS,将之PmeⅠ酶切线性化后与腺病毒基因组质粒pAdEasy-1共转化大肠杆菌BJ5183,同源重组质粒PacⅠ酶切鉴定后用脂质体转染293细胞,包装成重组体腺病毒颗粒Ad-ICOS。采用PCR方法对重组腺病毒颗粒进行鉴定,利用穿梭质粒pAdTrack-CMV中带有GFP报告基因,对病毒滴度和感染效率进行监测。通过Western Blot检测重组腺病毒感染后的293细胞上清中的ICOS胞外区蛋白。结果获得了重组人ICOS胞外区腺病毒载体颗粒。PCR检测表明重组腺病毒颗粒含有目的基因,滴度为2.1×1010pfu/ml。Western Blot检测到阳性目的条带。结论细菌内同源重组法是一种高效、简便、快捷的重组体腺病毒载体制备方法。所制备的重组体腺病毒Ad-ICOS在体外能有效表达相应的基因产物,为今后对ICOS胞外区的深入研究奠定了基础。 Objective To construct the recombinant adenovirus of human ICOS extracellular domain gene by using the method of homologous recombination in bacteria.Methods Human ICOS extracellular domain cDNA fragment was obtained from tonsil by nest RT-PCR.Then human ICOS extracellular domain cDNA fragment was subcloned into the shuttle plasmid pAdTrack-CMV.The resulting plasmid pAdtrack-cmv-ICOS was linearized with PmeⅠ and cotransformed into BJ5183 cells with adenovirus genomic plasmid of pAdEasy-1.The DNA of identified recombinant plasmid was digested with PacⅠand transfected to 293 cells to package recombinant adenovirus particles.The resulting recombinant adenovirus was identified by PCR and expression of ICOS extracellular domain protein secreting to supernatant by western blot.The titre was measured with the aid of GFP expression.Results Obtained the recombinant adenoviral Ad-ICOS.PCR and western blot test indicated the recombinant adenovirus contained the insert of human ICOS extracellular domain cDNA and expressed the ICOS extracellular domain protein.The titre of purified recombinant adenovirus was 2.1×10^(10)pfu/ml.Conclusion The method of homologous recombination in bacteria is a convenient and efficient method to make recombinant adenovirus,the resulting Ad-ICOS can effectively madiate target gene expression in cultured cells and paves a sound foundation for further study.
出处 《重庆医学》 CAS CSCD 2006年第16期1460-1462,共3页 Chongqing medicine
关键词 腺病毒 ICOS胞外区 同源重组 adenovirus human ICOS extracellular domain homologous recombinant
  • 相关文献

参考文献12

  • 1[1]Walunas TL,Bakker CY,Bluestone JA.CTLA-4 ligation blocks CD28-dependent T cell activation[J].J Exp Med,1996,183:2541
  • 2[2]Dong H,Zhu G,Tamada K,et al.B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J].Nat Med,1999,5(12):1365
  • 3[3]Hutloff A,Dittrich AM,Beier KC,et al.ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J].Nature,1999,397(6716):263
  • 4[4]Brodie D,Collins AV,Iaboni A,et al.LICOS,a primordial costimulatory ligand[J].Curr Biol,2005,10(6):333
  • 5[5]Yoshinaga SK,Whoriskey JS,Khare SD,et al.T cell co-stimulation through B7RP-1 and ICOS[J].Nature,1999,402(6763):827
  • 6[6]Wells WA.Amgen redux:ICOS corporation[J].Chem Biol,1999,6(1):R23
  • 7[7]Kopf M,Coyle AJ,Schmitz N,et al.Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection[J].J Exp Med,2000,92(1):53
  • 8[8]Ozkaynak E,Gao W,Shemmeri N,et al.Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection[J].Nat Immunol,2001,2(7):591
  • 9[9]Riley JL,Blair PJ,Musser JT,et al.ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement[J].J Immunol,2004,166(8):4943
  • 10[10]McAdam AJ,Greenwald RJ,Levin MA,et al.ICOS is critical for CD40-mediated antibody class switching[J].Nature,2003,409(6816):102

同被引文献29

  • 1李振宇,徐开林,潘秀英,鹿群先,何徐彭,孙海英,主鸿鹄.HIV-1慢病毒载体的构建及结构改造[J].中华血液学杂志,2004,25(9):571-572. 被引量:21
  • 2胡妙凤,尚世强.Dicer酶及其在RNA干扰中的作用[J].医学分子生物学杂志,2006,3(6):468-471. 被引量:2
  • 3Couzin J. Breakthrough of the year. SamU RNAs make big sblash[ J]. Science,2002,298:2296 - 2297.
  • 4Check E. Hopes rise for RNA therapy as mouse study hits target [ J ]. Nature,2004,432 : 173 - 178.
  • 5Schiffelers R M, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted stericaUy stabilized nanoparticle [ J ]. Nucleic Acids Res. ,2004,32(19) :e149.
  • 6Brown J M, Wilson W R. Exploiting tumour hypoxia in cancer treatment [ J ]. Nat Rev. Cancer, 2004,4 ( 6 ) : 437 - 447.
  • 7Welsh S J, Koh M Y, Powis G. The Hypoxic inducible stress response as a target for cancer drug discovery [ J ]. Semin Oncol, 2006,33 (4) :468 - 497.
  • 8Galanis A, Pappa A, Giannakakis A, et al. Reactive ox- ygen species and HIF-1 signalling in cancer[ J ]. Canc- er Lett. ,2008,266 ( 1 ) : 12 - 20.
  • 9Dempke W, Rie C, Grothey A, et al. Cyclooxygenase-2 : a novel target for cancer chemotherapy [ J ]. J Cancer Res Clin Oncol. ,2001,127(7) :411 -417.
  • 10Kyzas P A, Stefanou D, Agnantis N J. COX-2 expres- sion correlates with VEGF-C and lymphnode metasta- ses in patients with head and neck squamous cell carci- noma[ J]. Mod Pathol,2005,18( 1 ) :153 - 160.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部